- ... role in the multidis- ciplinary treatment of solid tumors in children. As the ... immunotherapy, and molecular bi- ology. New protocols are being ...
- NLM Digital Collections - Antiandrogen therapies for nonmetastatic castration-resistant prostate cancer : effectiveness ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, October 4, 2018... any of the following: a) a skeletal-related event (i.e., pathologic ... or regional tumor progression requiring surgery or radiation therapy.32 1. ...
- NLM Digital Collections - Targeted immune modulators for rheumatoid arthritis: effectiveness & value : evidence reportPublication: Boston, MA : Institute for Clinical and Economic Review, March 10, 2017... 1) 0* patient who received rescue 2) 0 ... rate, Deaths (Trial Name) van Vollenhoven RF The New 1) PBO+MTX (n=106) Neoplasm benign, Serious infections, n (%) Discontinuation due to AEs, ...
- NLM Digital Collections - AIDS bibliography, 1986-1987Publication: [Bethesda, Md.] : Reference Section, Public Services Division, National Library of Medicine, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1987... Human/ Human T-Cell Leukemia Virus- 'ISOLATION & PURIFICATION/ 'Immunotherapy/ Neoplasms-THERAPY Israelstam S ; Lambert S. Homosexuality and alcohol: observations and research ...
- NLM Digital Collections - Hematologic malignancies : regulatory considerations for use of minimal residual disease in ...Publication: Silver Spring, MD : Center for Drug Evaluation and Research, January 2020... Topic Drug Approval Drug Development Drugs, Investigational Hematologic Neoplasms -- drug therapy Investigational New Drug Application Neoplasm, Residual Endpoint Determination Leukemia, Lymphocytic, ...
- ... knew about what his and other clinics’ anti- tumor therapy and immunotherapy was. My son had all of that and ... a novel form of radiotherapy. A . number of additional studies are planned, ... try to define treatments that are effective and we are equally committed ...
- NLM Digital Collections - Gene therapies for sickle cell disease : final evidence reportPublication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 21, 2023... effectiveness of low-dose antithymocyte globulin versus other immunotherapies for treatment of new-onset type 1 diabetes. Diabetes Technology & Therapeutics. 2022; ...
- NLM Digital Collections - FDA oversightPublication: [Toronto, Ontario] : Thomson Reuters, 21-December-2020... work with stakeholders to advance the development of additional new, effective and safe therapies for these patients.” Patients with Hutchinson-Gilford progeria ...
- NLM Digital Collections - Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, November 22, 2022... in these groups and the potential benefits of new treatments. Finally, additional research is needed to determine which patient characteristics ... for a disease that commonly continues patients on therapies until death. See ... adjustments. Consistent with previous health technology assessments,""" ...
- NLM Digital Collections - FDA oversightPublication: [Toronto, Ontario] : Thomson Reuters, 20-December-2021... work with stakeholders to advance the development of additional new, effective and safe therapies for rare diseases, including Pompe disease." The FDA ...
100 results